To interrogate how PROM1/CD133 expression affects the biology of KMT2A::AFF1 iALL, we compared CD133+ and CD133–CRISPRKMT2A::AFF1 ALL. This evidence concerns the gene KMT2A and acute lymphoblastic leukemia.